AU2001253333A1 - Compounds and methods for modulating endothelial cell adhesion - Google Patents
Compounds and methods for modulating endothelial cell adhesionInfo
- Publication number
- AU2001253333A1 AU2001253333A1 AU2001253333A AU5333301A AU2001253333A1 AU 2001253333 A1 AU2001253333 A1 AU 2001253333A1 AU 2001253333 A AU2001253333 A AU 2001253333A AU 5333301 A AU5333301 A AU 5333301A AU 2001253333 A1 AU2001253333 A1 AU 2001253333A1
- Authority
- AU
- Australia
- Prior art keywords
- compounds
- methods
- cell adhesion
- endothelial cell
- modulating endothelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000021164 cell adhesion Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 210000002889 endothelial cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/544,782 US6610821B1 (en) | 1996-07-12 | 2000-04-07 | Compounds and methods for modulating endothelial cell adhesion |
US09544782 | 2000-04-07 | ||
PCT/US2001/011669 WO2001077146A2 (fr) | 2000-04-07 | 2001-04-09 | Composes et procedes de modulation de l'adhesion des cellules endotheliales |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001253333A1 true AU2001253333A1 (en) | 2001-10-23 |
Family
ID=24173575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001253333A Abandoned AU2001253333A1 (en) | 2000-04-07 | 2001-04-09 | Compounds and methods for modulating endothelial cell adhesion |
Country Status (6)
Country | Link |
---|---|
US (1) | US6610821B1 (fr) |
EP (1) | EP1311545A2 (fr) |
JP (1) | JP2003531120A (fr) |
AU (1) | AU2001253333A1 (fr) |
CA (1) | CA2405476A1 (fr) |
WO (1) | WO2001077146A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122623B2 (en) | 1996-07-12 | 2006-10-17 | Adherex Technologies, Inc. | Compounds and methods for modulating cell adhesion |
US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US20030130185A1 (en) * | 2000-09-29 | 2003-07-10 | David Bar-Or | Metal-binding compounds and uses therefor |
US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
AU2001231154A1 (en) * | 2000-01-24 | 2001-07-31 | Adherex Technologies Inc. | Peptidomimetic modulators of cell adhesion |
US20040167076A1 (en) * | 2003-02-14 | 2004-08-26 | Stamer W. Daniel | Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells |
EP1620066A4 (fr) * | 2003-05-07 | 2010-11-03 | Dmi Biosciences Inc | Methodes et produits de soins buccaux |
PT1806358E (pt) * | 2005-09-05 | 2010-05-28 | Immatics Biotechnologies Gmbh | Peptídeos associados a tumor ligando promiscuamente às moléculas do antigénio de leucócitos humanos (hla) da classe ii |
JP2009510105A (ja) * | 2005-09-28 | 2009-03-12 | バイオバスキュラー インコーポレーティッド | 血小板および細胞の接着、細胞移動、および炎症を阻止するための方法および組成物 |
US20110034396A1 (en) * | 2005-09-28 | 2011-02-10 | Biovascular, Inc. | Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions |
US20090291967A1 (en) * | 2008-03-05 | 2009-11-26 | Adherex Technologies, Inc. | Small molecule modulators of cell adhesion |
US8680150B2 (en) * | 2009-05-28 | 2014-03-25 | Ligand Pharmaceuticals, Inc. | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079600A (en) | 1987-03-06 | 1992-01-07 | Schnur Joel M | High resolution patterning on solid substrates |
JP2945680B2 (ja) | 1988-09-09 | 1999-09-06 | 旭硝子株式会社 | ペプチド誘導体およびその用途 |
US5231082A (en) | 1989-05-10 | 1993-07-27 | Monsanto Company | Cyclic peptide with anti-metastasis activity |
JPH05500504A (ja) | 1989-09-27 | 1993-02-04 | アテナ・ニュウロサイエンスィズ・インコーポレイテッド | 細胞付着阻止のための組成物及び使用方法 |
JPH06505962A (ja) | 1990-10-30 | 1994-07-07 | ラ ホヤ キャンサー リサーチ ファウンデーション | T−カドヘリン接着分子 |
US5245551A (en) * | 1991-04-10 | 1993-09-14 | University Of Utah Research Foundation | Method of determining extinction coefficient of fluorescent dye and protein concentration of dye-protein conjugate |
DE69222433D1 (de) | 1991-11-22 | 1997-10-30 | Yeda Res & Dev | Nicht-peptidische surrogate der arg-gly-asp sequenz und entsprechende pharmazeutische zusammensetzungen |
US5646250A (en) | 1992-04-17 | 1997-07-08 | Doheny Eye Institute | Cadherin polypeptides |
AU5669494A (en) | 1992-11-17 | 1994-06-08 | Yale University | Human homolog of the e-cadherin gene and methods based thereon |
US5591432A (en) | 1993-02-17 | 1997-01-07 | Becton, Dickinson And Company | Antibody to the neural cell adhesion molecule and methods of use |
US5665590A (en) | 1994-07-29 | 1997-09-09 | Systemix, Inc. | Method for isolating and directly cloning genes which encode cell-surface and secreted proteins |
WO1996040781A1 (fr) | 1995-06-07 | 1996-12-19 | Tanabe Seiyaku Co., Ltd. | INHIBITEURS PEPTIDIQUES CYCLIQUES D'ADHERENCE CELLULAIRE INDUITE PAR INTEGRINE β1 ET β¿2? |
GB9517098D0 (en) | 1995-08-21 | 1995-10-25 | Imperial College | Receptor |
WO1998002452A2 (fr) | 1996-07-12 | 1998-01-22 | Mcgill University | Composes et procedes pour la modulation de l'adherence cellulaire |
US6169071B1 (en) | 1996-07-12 | 2001-01-02 | Mcgill University | Compounds and methods for modulating cell adhesion |
US6551994B1 (en) | 1997-04-10 | 2003-04-22 | Mcgill University | Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
-
2000
- 2000-04-07 US US09/544,782 patent/US6610821B1/en not_active Expired - Fee Related
-
2001
- 2001-04-09 CA CA002405476A patent/CA2405476A1/fr not_active Abandoned
- 2001-04-09 EP EP01926823A patent/EP1311545A2/fr not_active Withdrawn
- 2001-04-09 JP JP2001575616A patent/JP2003531120A/ja not_active Withdrawn
- 2001-04-09 AU AU2001253333A patent/AU2001253333A1/en not_active Abandoned
- 2001-04-09 WO PCT/US2001/011669 patent/WO2001077146A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2405476A1 (fr) | 2001-10-18 |
WO2001077146A3 (fr) | 2003-03-06 |
US6610821B1 (en) | 2003-08-26 |
WO2001077146A2 (fr) | 2001-10-18 |
JP2003531120A (ja) | 2003-10-21 |
EP1311545A2 (fr) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001231154A1 (en) | Peptidomimetic modulators of cell adhesion | |
AU2001240126A1 (en) | Lithium cell | |
AU2001243525A1 (en) | Battery | |
EP1130098A3 (fr) | Osteorégulines mammifères | |
AU5991699A (en) | Quinolizinones as integrin inhibitors | |
AU4700700A (en) | Adhesives and method for making same | |
AU4478900A (en) | Compounds and methods for modulating beta-catenin mediated gene expression | |
AU2421797A (en) | Spirocycle integrin inhibitors | |
AU3074500A (en) | Proteasome inhibitors | |
AU2002213466A1 (en) | Compounds and methods for modulating ccr4 function | |
AU2001253333A1 (en) | Compounds and methods for modulating endothelial cell adhesion | |
AU2002211662A1 (en) | Nf-kappab inhibitors | |
AU6001401A (en) | Flat lithium cell | |
AU2832399A (en) | B cell inhibitors | |
AU6992600A (en) | Multispan girder | |
AU7553000A (en) | Gumming device | |
AU7125700A (en) | Enzyme inhibitors | |
AU2001293074A1 (en) | Human liver cell line | |
AU3235100A (en) | Prothease inhibitors | |
AU2001257430A1 (en) | Battery | |
AU2001257429A1 (en) | Battery | |
AU6179400A (en) | Multi-photodetector unit cell | |
AU6992500A (en) | Alphavbeta3 integrin inhibitors | |
AU2001233106A1 (en) | Method for sealing battery container | |
AU2002364612A1 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA |